Cosmos Health

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

VRAX

News

Health Care

Market-Moving Exclusives

Exclusives

General

COSM

Virax Biolabs supports HHS&#39;s focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research.

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.&#39;s HHS Goals On Vaccine Transparency

Stethoscope,Laying,On,Medicine,White,Pills,Money,With,Rx,Prescription

Equities

Contracts

Markets

Movers

Cosmos Health announced a ten-year contract with Provident Pharmaceuticals for production of four key drugs.

Cosmos Health Pockets 10-Year Manufacturing Deal With Provident Pharmaceuticals

Screenshot 2024-09-30 at 5.38.54 PM

Biotech

Movers & Shakers

Nestle Sponsored representing Registered Shares Series B

NSRGY

VTRS

How Cosmos Health&#39;s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Cosmos Health Inc

COSMOS PHARM CORP ORD by Cosmos Pharmaceutical Corp.

COSMOS Pharmaceutical Corp

COSMO ENERGY HLDGS CO LTD by Cosmo Energy Hldgs Co Ltd

Cosmo Energy Holdings Co Ltd

COSMO ENERGY UNSP/ADR by Cosmo Energy Hldgs Co Ltd

COSMO PHARMA NV ORD by Cosmo Pharmaceuticals NV

Cosmo Pharmaceuticals NV

COSMOSTEEL HOLDINGS INC by COSMOSTEEL HOLDINGS INC.

CosmoSteel Holdings Ltd

COSMOPOLITAN INTL HLDGS by Cosmopolitan International Holdings Ltd.

Cosmopolitan International Holdings Ltd

Cosmos - TrueUSD

Cosmos - United States Dollar

COSMOS GROUP HOLDINGS by Cosmos Group Holdings Inc.

Cosmos Group Holdings Inc

Press Releases

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Offerings

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Management

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

AdaptHealth

Akso Health Group - American Depositary Shares

Akso Health

Agape ATP

Cardinal Health

Cencora

Henry Schein

McKesson

Owens & Minor

Patterson Cos

Virax Biolabs Group Limited - Ordinary Shares

Virax Biolabs Group

Wellgistics Health

Cosmos Holdings

Buy,Or,Sell,Buttons,Concept.,Close,Up,Computer,Screen,View

Analyst Ratings

Taglich Brothers Maintains Speculative Buy Rating On Cosmos Health With $4 Price Target, Highlighting Potential Valuation Upside

Comments

Cosmos Health

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga